Similar Search Results

Promoting vaccinations - an analysis of measures taken by German statutory health insurers

Damm, Kathrin; Schubert, Jana M.; Schulenburg, … - In: Health economics review 1 (2011) 16, pp. 1-6

Introduction: Prophylactic vaccinations play a significant role in health care. As a relatively cost-effective preventive measure they can help to avert transmissible diseases and thus protect not only the vaccinated individuals themselves but also those who have not been vaccinated. In order to...

Persistent link: https://www.econbiz.de/10009503925

Pharma-Daten

Berlin : BPI; anfangs: Frankfurt, M. : BPI - Nachgewiesen 1972 - 1974; 5.1975 -

Persistent link: https://www.econbiz.de/10000363330

Promotion vaccinations - an analysis of measures taken by German statutory health insurers

Damm, Kathrin; Schubert, Jana M.; Schulenburg, … - In: Die Versorgung der Bevölkerung mit …, (pp. 176-189). 2014

Persistent link: https://www.econbiz.de/10010514731

Does managed care reduce health care expenditure? : evidence from spatial panel data

Ehlert, Andree; Oberschachtsiek, Dirk - In: International journal of health care finance and economics 14 (2014) 3, pp. 207-227

Persistent link: https://www.econbiz.de/10011308212

Willingness-to-pay for a new pharmaceutical : is it worth the money? : whose money?

Sennhauser, Michèle; Zweifel, Peter - In: Health economics and policy challenges in global …, (pp. 59-91). 2016

Persistent link: https://www.econbiz.de/10011476376

Sozioökonomie aus der Sicht der Kassen : Kriterien der Wirtschaftlichkeit von Arzneimitteln

Glaeske, Gerd - In: Pharmaökonomie in Deutschland : gesetzliche …, (pp. 47-53). 1995

Persistent link: https://www.econbiz.de/10001290863

Kosten-Nutzen-Bewertung der ambulanten Arzneimittelversorgung durch Kassen und Krankenversicherung

Glaeske, Gerd - In: Pharmaökonomie in Deutschland : gesetzliche …, (pp. 19-27). 1995

Persistent link: https://www.econbiz.de/10001290864

Pharmakoökonomie als Instrument im Wettbewerb der Krankenkassen? : Projektbericht

Braun, Günther E.; Baronowski, Stefan - 2000

Persistent link: https://www.econbiz.de/10001566589

Abseits der Vernunft : Ideologie und Wirklichkeit der Festbeträge

Nord, Dietrich - 1990

Persistent link: https://www.econbiz.de/10012877907

The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany

Dintsios, C. M.; Beinhauer, I. - In: Health economics review 10 (2020) 7, pp. 1-25

Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price … Health Insurance Funds. The analysis was conducted for all oncology pharmaceuticals that underwent the early benefit …. Further analyses should be performed when more oncology pharmaceuticals have passed the early benefit assessment. …

Persistent link: https://www.econbiz.de/10012291135

1
2
3
4
5
6
7
8
9
10
Next
Last